| Financial Year |
March 31 2023 |
| Monetary Funds |
50,755,755.34 |
| Held-for-trading Financial Assets |
1,984,505.13 |
| Notes Receivable |
14,593,190.78 |
| Accounts Receivable |
293,211,134.74 |
| Advances to Suppliers |
7,378,166.86 |
| Other Receivables |
32,619,901.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
90,175,321.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
20,966,587.11 |
| Other Current Assets |
520,477.30 |
| Total Current Assets |
531,925,619.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
20,015,834.90 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
49,242,284.18 |
| Under-construction Projects |
10,226,443.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
55,635,292.69 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
821,779.36 |
| Deferred Income Tax Assets |
7,162,773.86 |
| Other Non-Current Assets |
105,886,626.99 |
| Sub-Total of Non-Current Assets |
263,505,032.69 |
| Total Assets |
795,430,652.53 |
| Short-Term Loans |
47,224,176.21 |
| Trading Financial liabilities |
-- |
| Notes Payable |
69,361,054.43 |
| Accounts Payable |
154,177,391.38 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,490,208.21 |
| Taxes Payable |
3,223,437.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,775,074.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,810,434.54 |
| Other Current Liabilities |
3,803,394.77 |
| Sub-Total of Current Liabilities |
347,839,242.34 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
538,437.34 |
| Other Non-Current Liabilities |
34,563,032.45 |
| Sub-Total of Non-Current Liabilities |
36,083,443.61 |
| Total Liabilities |
383,922,685.95 |
| Paid-In Capital(Or Share Stock) |
134,000,000.00 |
| Capital Surplus |
161,222,960.11 |
| Surplus Reserve |
10,374,624.20 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
105,877,428.13 |
| Minority Stockholder's Interest |
32,954.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
411,475,012.44 |
| Owner's Equity（Stockholder's Equity） |
411,507,966.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
795,430,652.53 |
